Answers are grounded in this paper and cite their sources.
Demonstrates an innovative injectable hydrogel treatment for osteoarthritis, suggesting a novel anti-inflammatory approach.
Insufficient removal of reactive oxygen species (ROS) and macrophage M1/M2 polarization in the joint cavity are key factors in the progression of OA. Recent findings have shown that the combination of polydopamine (PDA) and platelet-rich plasma (PRP) is expected to be a promising strategy to treat OA. In light of the short retention period of nanodots in joints, we employed Poloxamer 407 (P407) and hyaluronic acid (HA) to synthesize a thermo-sensitive hydrogel as an injectable platform (HP, refer to HA@P407). Moreover, PDA@PEG (PP) NPs and PRP were synchronously added in the HP platform, called HPP@PP, to yield the treatment for OA. The multifunctional HPP@PP could effectively suppress the generation of ROS, inhibit ferroptosis, and facilitate M2-type macrophage polarization. This study sheds light on a novel promising option for anti-inflammatory treatment of OA via nanotechnology.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: